Yuta Ito

Chuo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

HAVCR2-mutated subcutaneous panniculitis-like T-cell lymphoma presenting with bone marrow infiltration and rapidly fatal hemophagocytic lymphohistiocytosis

HAVCR2-mutated subcutaneous panniculitis-like T-cell lymphoma presenting with bone marrow infiltration and rapidly fatal hemophagocytic lymphohistiocytosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 30, 2026

Utility of next-generation sequencing for diagnosing non-secretory multiple myeloma

Utility of next-generation sequencing for diagnosing non-secretory multiple myeloma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 08, 2026

Association between CD79B expression and polatuzumab vedotin efficacy, and therapy-induced changes in CD79B expression in diffuse large B-cell lymphoma.

Association between CD79B expression and polatuzumab vedotin efficacy, and therapy-induced changes in CD79B expression in diffuse large B-cell lymphoma.

Journal: Virchows Archiv : an international journal of pathology

Published: March 27, 2026

Correction: Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases.

Correction: Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases.

Journal: Cancer discovery

Published: February 13, 2026

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial.

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial.

Journal: Blood advances

Published: February 04, 2026

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

Journal: Blood advances

Published: February 04, 2026

The landscape of somatic alterations and their clinical relevance in extranodal NK/T-cell lymphoma

The landscape of somatic alterations and their clinical relevance in extranodal NK/T-cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 01, 2026

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies.

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies.

Journal: NPJ precision oncology

Published: June 30, 2025

Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors.

Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors.

Journal: Nature medicine

Published: May 19, 2025

Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas.

Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas.

Journal: JMA journal

Published: December 06, 2024

In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis.

In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis.

Journal: Blood advances

Published: December 04, 2024

Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system.

Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system.

Journal: Annals of hematology

Published: December 03, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026